BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 7704566)

  • 1. Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.
    Brown SA; Surman SL; Sealy R; Jones BG; Slobod KS; Branum K; Lockey TD; Howlett N; Freiden P; Flynn P; Hurwitz JL
    Viruses; 2010 Feb; 2(2):435-467. PubMed ID: 20407589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS 1995. Vaccines and immunology: overview.
    Montelaro RC; Wigzell H
    AIDS; 1995; 9 Suppl A():S111-2. PubMed ID: 8819577
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.
    Haynes BF; Yasutomi Y; Torres JV; Gardner MB; Langlios AJ; Bolognesi DP; Matthews TJ; Scearce RM; Jones DM; Moody MA
    Trans Assoc Am Physicians; 1993; 106():33-41. PubMed ID: 8036743
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV vaccines. Viral envelope fails to deliver?
    Bolognesi DP; Matthews TJ
    Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccines against HIV.
    Carmichael AJ; Sissons JG
    QJM; 1995 Feb; 88(2):77-9. PubMed ID: 7704566
    [No Abstract]   [Full Text] [Related]  

  • 6. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral immunity to HIV, SIV, and SHIV.
    Haigwood NL; Zolla-Pazner S
    AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucosal immunity, HIV transmission, and AIDS.
    Miller CJ; McGhee JR; Gardner MB
    Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of bivalent rgp120 vaccines to prevent HIV type 1 infection.
    Berman PW
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S277-89. PubMed ID: 9814956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.
    Wolfs TF; Nara PL; Goudsmit J
    Chem Immunol; 1993; 56():1-33. PubMed ID: 8383980
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.